Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06922942 · ClinicalTrials.gov registry record · NA

MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience

A NA study of Multiple Sclerosis, sponsored by Ad scientiam.

Active
Registry status
NA
Development phase
60
Enrollment target
4
Study locations

NCT06922942 is a NA study of Multiple Sclerosis that is active but no longer recruiting, run by Ad scientiam. The registered enrollment target is 60 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06922942, a NA study of Multiple Sclerosis, is active but no longer recruiting, sponsored by Ad scientiam.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
4
Study locations

Study Summary

This US multicenter, prospective cohort study aims to evaluate how MSCopilot can be seamlessly integrated into the current care pathway and identify potential optimizations to enhance its impact on both MS patients and clinicians, facilitating broader implementation. Specifically, the study will assess: * The overall integration of MSCopilot into routine clinical practice, * Patients' ability to use MSCopilot at home without supervision, * The need for patient support when using MSCopilot at home, * User behavior based on usage analytics data from the MSCopilot mobile app and dashboard, * Patient adherence to MSCopilot use in routine clinical practice, * The adequacy of the onboarding/training process for HCPs, * The effectiveness of HCPs onboarding/training in ensuring successful patient onboarding, * The variances in user behavior and adherence to MSCopilot use according to socio-demographic factors and EDSS scores

Conditions Studied

Multiple Sclerosis

Interventions

  • DEVICE MSCopilot Flower mobile application

Study Locations (4)

Louisiana

  • Jenny Feng - New Orleans

Missouri

  • Robert Naismith - St Louis

Oklahoma

  • Gabriel Pardo - Oklahoma City

Texas

  • Leorah Freeman - Austin

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-12
Est. Completion 2026-03-01
Phase NA

Sponsor

Ad scientiam

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06922942

The ClinicalTrials.gov registry entry for NCT06922942 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The listed sponsor is Ad scientiam, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which MSCopilot Flower mobile application is the first listed.

NCT06922942 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Louisiana, Missouri, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT06922942 about?

NCT06922942 is a clinical study titled "MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience". This US multicenter, prospective cohort study aims to evaluate how MSCopilot can be seamlessly integrated into the current care pathway and identify potential optimizations to enhance its impact on both MS patients and clinicians, facilitating broader implementation. Specifically, the study will ass...

What is the current status of trial NCT06922942?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-12. Estimated completion is 2026-03-01.

What conditions does trial NCT06922942 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT06922942?

The interventions under investigation include: MSCopilot Flower mobile application (DEVICE).

Who is sponsoring clinical trial NCT06922942?

This trial is sponsored by Ad scientiam, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06922942 being conducted?

This trial has 4 study locations across Louisiana, Missouri, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Louisiana

All trials with a study site in Louisiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.